Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE randomized trial

Alexandre Mebazaa, Markku S. Nieminen, Milton Packer, Alain Cohen-Solal, Franz X. Kleber, Stuart J. Pocock, Roopal Thakkar, Robert J. Padley, Pentti Põder, Matti Kivikko

Research output: Contribution to journalArticlepeer-review

858 Scopus citations

Fingerprint

Dive into the research topics of 'Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences